Skip to main content
Caplight Logo









Wuhan Bio-Raid Biotechnology

Wuhan Bio-Raid Biotechnology

Private
WuhanHealthcare & Life Scienceshttps://www.bio-raid.com/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Wuhan Bio-Raid Biotechnology is a biotechnology company that develops CAR-T cell immunotherapy for the treatment of blood tumors, solid tumors, and viral infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

CAR-T cell therapyimmunotherapycell therapycancer immunotherapyautologous cell therapyhematologic malignanciessolid tumor treatmentcGMP manufacturingcell engineeringoncologyclinical trialbiopharmaceuticallentiviral vectorliving drugs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wuhan Bio-Raid Biotechnology Comparables

Compare Wuhan Bio-Raid Biotechnology with similar companies based on industry and business-model similarity.

Wuhan Bio-Raid Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai Unicar-Therapy Bio-medicine Technology
88%
Chongqing Precision Biotech Co., Ltd.
88%
Shanghai YaKe Biotechnology Co., Ltd.
87%

Wuhan Bio-Raid Biotechnology Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 547% MoM.

  • Feb 2, 2026

    Monthly visitors grew 320% MoM, reaching 1.1K.

Wuhan Bio-Raid Biotechnology Filings

Explore SEC and related filing metadata, where available.

Wuhan Bio-Raid Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Wuhan Bio-Raid Biotechnology's valuation, stock price, and market status.

Is Wuhan Bio-Raid Biotechnology a public or private company?

Wuhan Bio-Raid Biotechnology is a private company.

What is the current stock price of Wuhan Bio-Raid Biotechnology?

Wuhan Bio-Raid Biotechnology is a private company with no public stock price. Caplight tracks Wuhan Bio-Raid Biotechnology's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Wuhan Bio-Raid Biotechnology worth (valuation)?

Valuation information for Wuhan Bio-Raid Biotechnology is not publicly available.

Can I buy Wuhan Bio-Raid Biotechnology stock?

Wuhan Bio-Raid Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Wuhan Bio-Raid Biotechnology's last funding round?

Funding round information for Wuhan Bio-Raid Biotechnology is not publicly available.

Who are the main investors in Wuhan Bio-Raid Biotechnology?

Investor information for Wuhan Bio-Raid Biotechnology is not publicly disclosed.

Will Wuhan Bio-Raid Biotechnology IPO soon?

No public IPO plans have been announced for Wuhan Bio-Raid Biotechnology.

How can I track Wuhan Bio-Raid Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Wuhan Bio-Raid Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWuhan
Employee Range2
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?